Discover trends, market shifts, and competitive outlooks for the coronary stents industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Coronary Stents Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

In recent times, the coronary stents market has experienced robust growth. The market is projected to expand from $11.06 billion in 2024 to $12.02 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%. The historical growth trend can be traced back to various factors such as a growing inclination towards minimally invasive procedures, accessibility to healthcare in upcoming markets, increased healthcare spending, upward trend in percutaneous coronary interventions, and an increase in the cohort of cardiologists._x000D_

_x000D_

The market size for coronary stents is projected to witness significant expansion in the forthcoming years. The market’s value is predicted to rise to $16.5 billion by the year 2029, having a compound annual growth rate (CAGR) of 8.3%. This projected growth during the forecast period can be linked to several factors including an upsurge in cardiovascular diseases, an ageing population, increased cognizance about heart health, supportive governmental schemes and funding, along with an increase in lifestyle-related diseases. Key trends expected during this forecast period encompass advancements in stent technology, breakthroughs in imaging technologies, strategic alliances and partnerships, and developments in stent materials and technological integration with digital health._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Coronary Stents Market?#_x000D_

The hike in the cases of cardiovascular diseases (CVDs) is foreseen to boost the development of the coronary stent market. CVDs encompass a bunch of disorders associated with the heart and blood vessels, inclusive of conditions such as coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases can be linked to factors like an aging population, an upsurge in risk factors such as obesity, diabetes, lack of exercise, poor nutrition, and increased stress levels. A coronary stent is vital for treating cardiovascular diseases as it aids in opening up narrowed or blocked coronary arteries, enhancing blood circulation to the heart, and minimizing the risk of heart attacks. For instance, a report by the American College of Cardiology in August 2022, a non-profit medical organization based in the U.S., forecasted a sizable increase in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicts diabetes to escalate by 39.3% to 55 million people, dyslipidemia to surge by 27.6% to 126 million, hypertension to go up by 25.1% to 162 million, and obesity to increase by 18.3% to 126 million. The largest increase is projected for stroke (33.8% increase to 15 million) and heart failure (33.4% hike to 13 million), followed by ischemic heart disease (30.7% rise to 29 million) and heart attacks (16.9% boost to 16 million). Hence, the escalating cases of cardiovascular diseases (CVDs) are propelling the expansion of the coronary stent market._x000D_

_x000D_

#Which Key Market Segments Comprise the Coronary Stents Market and Drive Its Revenue Growth?#_x000D_

The coronary stents market covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents_x000D_

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies_x000D_

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer_x000D_

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents_x000D_

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents_x000D_

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents_x000D_

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents_x000D_

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents_x000D_

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents_x000D_

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents_x000D_

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents_x000D_

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents_x000D_

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents_x000D_

_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Coronary Stents Market Expansion Across the Globe?#_x000D_

North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering theCoronary Stents Market Direction?#_x000D_

Leading corporations in the coronary stent market are focusing on the innovation of products like drug-eluting stents, to decrease the necessity for repeated procedures, a common issue with bare-metal stents. Drug-eluting stents are exclusive coronary stents that are covered with medicine which aids in avoiding the arteries’ re-narrowing by slowly releasing the drugs over a period. For instance, Abbott, an American healthcare firm, in May 2024, introduced the XIENCE Sierra Everolimus (a drug) Eluting Coronary Stent System in India. What makes the XIENCE Sierra stent unique is its refined design, new mode of delivery, and its exclusive size range, all tailored to handle complex cases. It maintains the special coating that helps to minimize the chance of re-blockage of arteries, which is a shared feature among all XIENCE stents. This particular stent holds a noteworthy safety record, and it is supported by more than 120 clinical trials which involve over 120,000 patients._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report_x000D_

_x000D_

#How Is the Coronary Stents Market Conceptually Defined?#_x000D_

Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model